|1.||Bresolin, N: 2 articles (09/2009 - 05/2009)|
|2.||Zucca, C: 2 articles (09/2009 - 05/2009)|
|3.||Pecori, A: 2 articles (09/2009 - 05/2009)|
|4.||Bengesser, S A: 1 article (03/2015)|
|5.||Schöggl, H: 1 article (03/2015)|
|6.||Mörkl, S: 1 article (03/2015)|
|7.||Bayer, D: 1 article (03/2015)|
|8.||Kapfhammer, H P: 1 article (03/2015)|
|9.||Kozlova, I M: 1 article (09/2006)|
|10.||Vorob'eva, O V: 1 article (09/2006)|
|4.||High Pressure Neurological Syndrome (High Pressure Nervous Syndrome)
09/01/1988 - "Effect of benzazole-related centrally acting muscle relaxants on HPNS."
09/01/1988 - "Their anti-HPNS properties, like those previously established for the mephenesin group of centrally acting muscle relaxants, seem to be related to their ability to antagonize the convulsive action of strychnine. "
09/01/1988 - "A series of benzazole-related, centrally acting muscle relaxants, comprising benzimidazole, chlorzoxazone, and zoxazolamine, were found to give substantial protection against the tremors and convulsions associated with the high pressure neurologic syndrome (HPNS) in the mouse. "
|5.||Muscle Spasticity (Spastic)
05/01/2009 - "Few trials have compared different central muscle relaxants in the treatment of spastic palsy. "
09/01/2009 - "Central muscle relaxants are a clinical option in patients with spastic palsy. "
01/01/1986 - "It is suggested that the depression by tizanidine of gamma-system and spinal reflexes contribute to muscle relaxation and anti-spastic effects and that mechanisms of action are different from those of other centrally acting muscle relaxants such as mephenesin and benzodiazepines."
01/01/1978 - "Rats receiving clodanolene sodium for up to 30 days evidenced a downward trend in gross observation score of skeletal muscle relaxation, but the extent of twitch inhibition was the same on day 30 as on day 1. In an animal model of muscle spasticity (Straub-tail mouse), clodanolene sodium has been shown to be more efficacious for induction of skeletal muscle relaxation than neuromuscular blocking agents, local anesthetics, or centrally-acting muscle relaxants. "
|6.||Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
|7.||Oxazolidinones (2 Oxazolidone)
|10.||Neuromuscular Blocking Agents